Essential Characteristics of Pharmacogenomics Study Publications

Caroline F. Thorn, Michelle Whirl-Carrillo, Houda Hachad, Julie A. Johnson, Ellen M. McDonagh, Mark J. Ratain, Mary V. Relling, Stuart A. Scott, Russ B. Altman, Teri E. Klein

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Pharmacogenomics (PGx) can be seen as a model for biomedical studies: it includes all disease areas of interest and spans in vitro studies to clinical trials, while focusing on the relationships between genes and drugs and the resulting phenotypes. This review will examine different characteristics of PGx study publications and provide examples of excellence in framing PGx questions and reporting their resulting data in a way that maximizes the knowledge that can be built on them.

Original languageEnglish
Pages (from-to)86-91
Number of pages6
JournalClinical Pharmacology and Therapeutics
Issue number1
StatePublished - Jan 2019


Dive into the research topics of 'Essential Characteristics of Pharmacogenomics Study Publications'. Together they form a unique fingerprint.

Cite this